Arucarea SRL
Arucarea reported total assets of 73,983 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Arucarea shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Arucarea's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Arucarea's financial analysis
- Solvency28.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Arucarea
Arucarea's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0650.576.822
- VAT number
- BE0650576822
- Peppol
- Registered · 0208:0650576822 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Mar 2016
- Registered office
- 2360 Oud-Turnhout
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Arucarea (SRL) has been based in Oud-Turnhout since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,699 € and equity of 20,778 €; its revenue is not published. Its solvency stands at 28.1%, below the median of its sector (44.2%).
Companies similar to Arucarea
Companies in the same business, of comparable size and area, outside its group.
- Sagenex Retail sale of pharmaceutical products Namur · balance sheet 73,820 €
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Arkophar Retail sale of pharmaceutical products Zutendaal · balance sheet 73,718 €
- NED Pharma Retail sale of pharmaceutical products Mons · balance sheet 74,278 €
- Apotheker Van De Weghe Karen Retail sale of pharmaceutical products Sint-Martens-Latem · balance sheet 73,167 €
- ESPharma Retail sale of pharmaceutical products Anderlecht · balance sheet 74,825 €
- Apr. ZEYREK Retail sale of pharmaceutical products Leuven · balance sheet 72,982 €
- LouksPharma Retail sale of pharmaceutical products Fernelmont · balance sheet 72,654 €
Frequently asked questions about Arucarea
What is the revenue of Arucarea?
Arucarea files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Arucarea?
In Belgium, the VAT number is the company number prefixed with BE: BE0650576822 for Arucarea, if the company is VAT-registered. Its company number (CBE) is 0650.576.822.
Where is the registered office of Arucarea?
According to the CBE register, the registered office of Arucarea is in 2360 Oud-Turnhout.
What is the equity of Arucarea?
At the close of the 2025 financial year, the equity of Arucarea amounts to 20,778 €, a solvency of 28.1% of total assets.
Who manages Arucarea?
The register lists 1 active mandates at Arucarea. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Arucarea
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →